Esketamine: Completed Phase III enrollment

Auris completed enrollment of >330 patients with acute peripheral tinnitus following traumatic cochlear injury or otitis media

Read the full 175 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE